arrow
O

Olaf Eickmeier

goethe university frankfurt
H指数:21
被引数:1,458

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Relating Improvement in Gastrointestinal (CFAbd-Score©) and Sinonasal (SNOT) Symptoms During Therapy With Elexacaftor/Tezacaftor/Ivacaftor in CF Patients

与使用Elexacaftor/Tezacaftor/Ivacaftor治疗期间,囊性纤维化患者胃肠道(CFAbd-Score©)和鼻窦(SNOT)症状的改善相关联

2026-02-130
PRE
Bronchoscopy Identifies Bacterial Airway Colonization and Comorbidities in Preschool Children With Refractory Respiratory Symptoms: A Retrospective Study

支气管镜检查可识别难治性呼吸道症状学龄前儿童的细菌气道定植和合并症:一项回顾性研究

2026-01-060
OAAI
The novel CFAbd-Score.kidⒸ reveals a significant decline of abdominal symptoms in children with Cystic fibrosis aged 6 through 11 years on Elexacaftor/Tezacaftor/Ivacaftor – first results

新型CFAbd-Score.kidⒸ显示,在服用Elexacaftor/Tezacaftor/Ivacaftor的6至11岁囊性纤维化患儿中,腹部症状显著下降——初步结果

2025-09-120
OAAI
Validation of the CFAbd-Score.kid©, a Novel gastrointestinal patient reported outcome measure, specific for children with cystic fibrosis

CFAbd-Score.kid©的验证,一种新型的针对囊性纤维化儿童患者的胃肠道患者报告结局测量方法

2025-07-230
OAAI
Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry
2023-09-0116
OA
Comparison of the Lung Clearance Index in Preschool Children With Primary Ciliary Dyskinesia and Cystic Fibrosis

原发性睫状运动障碍和囊性纤维化学龄前儿童肺清除指数的比较

CHEST
IF8.6
2022-09-018
PRE
Molecular Epidemiology of Mycobacterium abscessus Isolates Recovered from German Cystic Fibrosis Patients

从德国囊性纤维化患者中回收的脓肿分枝杆菌分离株的分子流行病学

2022-08-3114
OAAI